QQ客服 官方微博 反馈留言

	Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple negative metastatic breast cancer
	Zhang, Jian; Wang, Leiping; Wang, Zhonghua; Wang, Biyun; Cao, Jun; Lv, Fangfang; Zhang, Sheng; Shao, Zhimin; Hu, Xichun
刊名	ONCOTARGET
	2017
卷号	8期号:45
关键词	metronomic chemotherapy oral cyclophosphamide docetaxel metastatic breast cancer
ISSN号	1949-2553
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3616156
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Zhang, Jian,Wang, Leiping,Wang, Zhonghua,et al. Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple negative metastatic breast cancer[J]. ONCOTARGET,2017,8(45).
APA	Zhang, Jian.,Wang, Leiping.,Wang, Zhonghua.,Wang, Biyun.,Cao, Jun.,...&Hu, Xichun.(2017).Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple negative metastatic breast cancer.ONCOTARGET,8(45).
MLA	Zhang, Jian,et al."Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple negative metastatic breast cancer".ONCOTARGET 8.45(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。